About: covid:PMC7319627

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:PMC7319627 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
Creator	Akula, Shaw Blalock, William Piazzi, Manuela Abrams, Stephen Basecke, Jorg Candido, Saverio Cervello, Melchiorre Cocco, Lucio Follo, Matilde Lerpiriyapong, Kvin Libra, Massimo Martelli, Alberto McCubrey, James Montalto, Giuseppe Notarbartolo, Monica Ramazzotti, Giulia Ratti, Stefano Steelman, Linda
is schema:about of	named entity 'affect expression' named entity 'COVID-19 outbreak' named entity 'cell type' named entity 'Losartan' named entity 'approved drugs' named entity 'COVID' named entity 'IFNβ' named entity 'SARS-CoV2' named entity 'protein kinase' named entity 'chronic lymphocytic leukemia' named entity 'glisoxepide' named entity 'COVID' named entity 'SARS-CoV-2' named entity 'AT1R' named entity 'MoAb' named entity 'Chicago' named entity 'COVID' named entity 'sirtuin' named entity 'mortality rate' named entity 'infection' named entity 'malignancies' named entity 'COVID' named entity 'Neutropenia' named entity 'programmed death' named entity 'Infection' named entity 'all-cause mortality' named entity 'personal protective equipment (PPE' named entity 'hydroxychloroquine' named entity 'hepatotoxicity' named entity 'first-line treatment' named entity 'COVID' named entity 'IL-9' named entity 'chemokines' named entity 'HCC' named entity 'clinical trial' named entity 'hormone' named entity 'azithromycin' named entity 'tablets' named entity 'COVID-19 disease' named entity 'COVID' named entity 'hormonal therapy' named entity 'Spanish flu' named entity 'protein targets' named entity 'Coronavirus' named entity 'hydroxychloroquine' named entity 'gastrointestinal cancer' named entity 'interstitial pneumonitis' named entity 'tablets' named entity 'nutraceutical' named entity 'COVID' named entity 'skin cancer' named entity 'FURIN' named entity 'Infection' named entity 'FDA' named entity 'Israel' named entity 'Ruxolitinib' named entity 'ClinicalTrials.gov' named entity 'aerosol' named entity 'Oncology' named entity 'COVID' named entity 'New York City' named entity 'JAK inhibitor' named entity 'quercetin' named entity 'rapamycin' named entity 'ClinicalTrials.gov' named entity 'COVID-19' named entity 'human papilloma virus' named entity 'IL-8' named entity 'chemotherapy' named entity 'COVID' named entity 'ClinicalTrials.gov' named entity 'ASCT' named entity 'cytokines' named entity 'Acalabrutinib' named entity 'supplemental oxygen' named entity 'health care professionals' named entity 'immunosuppressive drugs' named entity 'clinical trials' named entity 'FDA' named entity 'PARP inhibitors' named entity 'COVID' named entity 'infection'

Attributes

Values

Creator

Akula, Shaw
Blalock, William
Piazzi, Manuela
Abrams, Stephen
Basecke, Jorg
Candido, Saverio
Cervello, Melchiorre
Cocco, Lucio
Follo, Matilde
Lerpiriyapong, Kvin
Libra, Massimo
Martelli, Alberto
McCubrey, James
Montalto, Giuseppe
Notarbartolo, Monica
Ramazzotti, Giulia
Ratti, Stefano
Steelman, Linda

is schema:about of

named entity 'affect expression'
named entity 'COVID-19 outbreak'
named entity 'cell type'
named entity 'Losartan'
named entity 'approved drugs'
named entity 'COVID'
named entity 'IFNβ'
named entity 'SARS-CoV2'
named entity 'protein kinase'
named entity 'chronic lymphocytic leukemia'
named entity 'glisoxepide'
named entity 'COVID'
named entity 'SARS-CoV-2'
named entity 'AT1R'
named entity 'MoAb'
named entity 'Chicago'
named entity 'COVID'
named entity 'sirtuin'
named entity 'mortality rate'
named entity 'infection'
named entity 'malignancies'
named entity 'COVID'
named entity 'Neutropenia'
named entity 'programmed death'
named entity 'Infection'
named entity 'all-cause mortality'
named entity 'personal protective equipment (PPE'
named entity 'hydroxychloroquine'
named entity 'hepatotoxicity'
named entity 'first-line treatment'
named entity 'COVID'
named entity 'IL-9'
named entity 'chemokines'
named entity 'HCC'
named entity 'clinical trial'
named entity 'hormone'
named entity 'azithromycin'
named entity 'tablets'
named entity 'COVID-19 disease'
named entity 'COVID'
named entity 'hormonal therapy'
named entity 'Spanish flu'
named entity 'protein targets'
named entity 'Coronavirus'
named entity 'hydroxychloroquine'
named entity 'gastrointestinal cancer'
named entity 'interstitial pneumonitis'
named entity 'tablets'
named entity 'nutraceutical'
named entity 'COVID'
named entity 'skin cancer'
named entity 'FURIN'
named entity 'Infection'
named entity 'FDA'
named entity 'Israel'
named entity 'Ruxolitinib'
named entity 'ClinicalTrials.gov'
named entity 'aerosol'
named entity 'Oncology'
named entity 'COVID'
named entity 'New York City'
named entity 'JAK inhibitor'
named entity 'quercetin'
named entity 'rapamycin'
named entity 'ClinicalTrials.gov'
named entity 'COVID-19'
named entity 'human papilloma virus'
named entity 'IL-8'
named entity 'chemotherapy'
named entity 'COVID'
named entity 'ClinicalTrials.gov'
named entity 'ASCT'
named entity 'cytokines'
named entity 'Acalabrutinib'
named entity 'supplemental oxygen'
named entity 'health care professionals'
named entity 'immunosuppressive drugs'
named entity 'clinical trials'
named entity 'FDA'
named entity 'PARP inhibitors'
named entity 'COVID'
named entity 'infection'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software